{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:28:52Z","timestamp":1761596932724,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.canlet.2005.08.030","type":"journal-article","created":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T08:44:45Z","timestamp":1130229885000},"page":"83-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Combination vaccine of dendritic cells (DCs) and T cells effectively suppressed preestablished malignant melanoma in mice"],"prefix":"10.1016","volume":"240","author":[{"given":"Hidetsugu","family":"Asada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunao","family":"Kishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyo","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Shin-Ya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osam","family":"Mazda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2005.08.030_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2005.08.030_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s002620050317","article-title":"Dendritic cells presenting tumor antigen","volume":"43","author":"Shurin","year":"1996","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2005.08.030_bib3","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.4049\/jimmunol.159.11.5391","article-title":"Processing of engulfed apoptotic bodies yields T cell epitopes","volume":"159","author":"Bellone","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2005.08.030_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4049\/jimmunol.163.1.130","article-title":"Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines","volume":"163","author":"Ronchetti","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2005.08.030_bib5","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V90.4.1594","article-title":"Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines","volume":"90","author":"Brossart","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2005.08.030_bib6","first-page":"11","article-title":"Review: dendritic cell immunotherapy for melanoma","volume":"14","author":"Hadzantonis","year":"1999","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.canlet.2005.08.030_bib7","first-page":"399","article-title":"Role of chemokines in trafficking of lymphocytes and dendritic cells","volume":"72","author":"Yoshie","year":"2000","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.canlet.2005.08.030_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1359-6101(01)00033-8","article-title":"Chemokines in cancer","volume":"13","author":"Vicari","year":"2002","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.canlet.2005.08.030_bib9","series-title":"Frontiers in Immuno-Gene Therapy","first-page":"1","article-title":"Tumor immunity and immuno-gene therapy of cancer","author":"Mazda","year":"2004"},{"key":"10.1016\/j.canlet.2005.08.030_bib10","article-title":"Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12","author":"Okada","year":"2004","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2005.08.030_bib11","first-page":"2062","article-title":"T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy","volume":"61","author":"Kirk","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2005.08.030_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/cimm.1999.1585","article-title":"Enhanced immune response to the melanoma antigen gp100 using recombinant adenovirus-transduced dendritic cells","volume":"198","author":"Wan","year":"1999","journal-title":"Cell Immunol."},{"key":"10.1016\/j.canlet.2005.08.030_bib13","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1084\/jem.186.7.1177","article-title":"Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors","volume":"186","author":"Ashley","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2005.08.030_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1525-0016(03)00044-3","article-title":"Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells","volume":"7","author":"Siders","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2005.08.030_bib15","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.4049\/jimmunol.170.7.3806","article-title":"Tumor-derived TGF-beta reduces the efficacy of dendritic cell\/tumor fusion vaccine","volume":"170","author":"Kao","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2005.08.030_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells","volume":"2","author":"Hsu","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2005.08.030_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.183.1.317","article-title":"Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo","volume":"183","author":"Paglia","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2005.08.030_bib18","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.4049\/jimmunol.172.4.2232","article-title":"Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses","volume":"172","author":"Breckpot","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2005.08.030_bib19","first-page":"3394","article-title":"Dendritic cells pulsed with HER-2\/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer","volume":"8","author":"Kono","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2005.08.030_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.leu.2401311","article-title":"Generation of bcr-abl specific cytotoxic T-lymphocytes by using dendritic cells pulsed with bcr-abl (b3a2) peptide: its applicability for donor leukocyte transfusions in marrow grafted CML patients","volume":"13","author":"Osman","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2005.08.030_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00002371-200001000-00011","article-title":"Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma","volume":"23","author":"Hinkel","year":"2000","journal-title":"J. Immunother."},{"key":"10.1016\/j.canlet.2005.08.030_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00262-001-0255-1","article-title":"Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial","volume":"51","author":"Hernando","year":"2002","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2005.08.030_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00262-003-0375-x","article-title":"Durable complete clinical responses in a phase I\/II trial using an autologous melanoma cell\/dendritic cell vaccine","volume":"52","author":"O'Rourke","year":"2003","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2005.08.030_bib24","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1073\/pnas.0530311100","article-title":"Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction","volume":"100","author":"Schmollinger","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2005.08.030_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1473-0502(02)00041-1","article-title":"Dendritic cells in vaccination therapies of malignant diseases","volume":"27","author":"Brossart","year":"2002","journal-title":"Transfus. Apheresis Sci."},{"key":"10.1016\/j.canlet.2005.08.030_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s002620100213","article-title":"Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene","volume":"50","author":"Kusumoto","year":"2001","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2005.08.030_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1097-0215(20000501)86:3<385::AID-IJC13>3.0.CO;2-T","article-title":"Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells","volume":"86","author":"Mackensen","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2005.08.030_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1034\/j.1600-065X.2000.17717.x","article-title":"Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression","volume":"177","author":"Sallusto","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.canlet.2005.08.030_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1189\/jlb.0603250","article-title":"In situ demonstration of dendritic cell migration from rat intestine to mesenteric lymph nodes: relationships to maturation and role of chemokines","volume":"75","author":"Kobayashi","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.canlet.2005.08.030_bib30","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/eji.1830270812","article-title":"The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium","volume":"27","author":"Rubartelli","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2005.08.030_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2005.08.030_bib32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.188.7.1359","article-title":"Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes","volume":"188","author":"Albert","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2005.08.030_bib33","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.gt.3301519","article-title":"In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice","volume":"8","author":"Kishida","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2005.08.030_bib34","first-page":"287","article-title":"The use of Matrigel to facilitate the establishment of human cancer cell lines as xenografts","volume":"88","author":"Mullen","year":"2004","journal-title":"Methods Mol. Med."},{"key":"10.1016\/j.canlet.2005.08.030_bib35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.gt.3301912","article-title":"Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo","volume":"10","author":"Nakanishi","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2005.08.030_bib36","first-page":"3542","article-title":"Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells","volume":"60","author":"Hoffmann","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2005.08.030_bib37","first-page":"2347","article-title":"Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells","volume":"62","author":"Schnurr","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2005.08.030_bib38","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.192.11.1535","article-title":"Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells","volume":"192","author":"Berard","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2005.08.030_bib39","first-page":"3340","article-title":"Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration","volume":"59","author":"Eggert","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2005.08.030_bib40","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.4049\/jimmunol.164.6.3095","article-title":"CD8+T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity","volume":"164","author":"Hermans","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2005.08.030_bib41","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1084\/jem.189.3.593","article-title":"Antigen-pulsed CD8alpha+ dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node","volume":"189","author":"Smith","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2005.08.030_bib42","first-page":"56","article-title":"Migration of human dendritic cells after injection in patients with metastatic malignancies","volume":"59","author":"Morse","year":"1999","journal-title":"Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383505007986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383505007986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:26:53Z","timestamp":1759591613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383505007986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0304383505007986"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2005.08.030","relation":{},"ISSN":["0304-3835"],"issn-type":[{"type":"print","value":"0304-3835"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination vaccine of dendritic cells (DCs) and T cells effectively suppressed preestablished malignant melanoma in mice","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2005.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}